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Extended Domains Controlled by Monomer Structure
Zachariah Lockhart and Peter C. Knipe*
Abstract: Foldamers are an important class of abiotic macro-
molecules, with potential therapeutic applications in the
disruption of protein–protein interactions. The majority
adopt a single conformational motif such as a helix. A class
of foldamer is now introduced where the choice of heterocycle
within each monomer, coupled with a strong conformation-
determining dipole repulsion effect, allows both helical and
extended conformations to be selected. Combining these
monomers into hetero-oligomers enables highly controlled
exploration of conformational space and projection of side-
chains along multiple vectors. The foldamers were rapidly
constructed via an iterative deprotection-cross-coupling
sequence, and their solid- and solution-phase conformations
were analysed by X-ray crystallography and NMR and CD
spectroscopy. These molecules may find applications in protein
surface recognition where the interface does not involve
canonical peptide secondary structures.
NatureQs oligomers carry out many of the biological
functions necessary to sustain life and carry genetic informa-
tion. The majority of proteins adopt a structure determined
entirely by the primary sequence of amino acids,[1] containing
a-helical, b-strand/sheet, and loop domains combined in
a tertiary fold. A key determinant of protein conformation is
the secondary structural propensity (SSP) of the constituent
amino acids; that is, the structure of each monomer creates
a thermodynamic driving force for it to occupy a particular
secondary structural environment (Figure 1A).[2]
For decades chemists have sought to mimic the structural
and functional diversity of biopolymers using synthetic
oligomers, a field now known as foldamer chemistry.[3] As
well as catalytic[4] and signalling applications,[5] foldamers
have enjoyed success when applied to problems in chemical
biology[3b] such as modulating protein–protein interactions
(PPIs).[6] One approach to controlling global conformation is
to exploit non-covalent interactions between adjacent mono-
mers. Gong[7] and Huc[8] have used hydrogen bonding to
control curvature in aryl amide foldamers, while Aggarwal[9]
employed the syn-pentane interaction as a controlling force in
simple hydrocarbon foldamers.[10] Lehn pioneered the use of
dipolar repulsion as a controlling element in foldamer design,
and exploited aromatic heterocycles as shape codons[11] for
helix formation owing to their well-defined bond angles and
strong dipoles.[12] Dipole repulsion between carbonyl groups
has also been explored;[13] Clayden used this effect as
a stereochemical relay to achieve remote (1,23)-asymmetric
induction in an oligoxanthene foldamer.[14]As a result of these
and other approaches, chemists are now able to synthesize
foldamers to reliably adopt conformations analogous to
protein secondary structures.[15]
Efforts have been made to go beyond forming simple
secondary structural motifs. Super-secondary helical foldamer
bundles and b-helices have been reported,[16] and recently
Horne has used b-,N-methyl, and other modified amino acids
to stabilize a natural zinc finger domain.[17] Similarly, Kir-
shenbaum has used the presence of peptoids, in combination
with cation–p interactions, to form stable b-loop-PPII helix
tertiary peptidomimetics.[18] The task of combining entirely
unnatural secondary domains in a single foldamer capable of
mimicking tertiary structure (called tyligomers by Moore[3c])
remains a central challenge, although Huc recently disclosed
a remarkable helix–sheet–helix tertiary foldamer.[19]
Figure 1. A) Nature’s control of tertiary structure with amino acid
secondary structural propensities (SSPs) as a determinant. Shown is
a truncate of ephrin A2 receptor protein kinase (PDB: 5NKB). Side-
chains A664 and V681 are highlighted. B) Left: aryl-imidazolidin-2-one
monomers preferring an extended (linear) conformation due to dipolar
repulsion. Selected dipoles are indicated. Right: pyrimidine-imidazoli-
din-2-one monomers preferring a helical conformation. Centre: repre-
sentation of multi-domain foldamer structures.
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Inspired by Thompson and HamiltonQs use of dipole
repulsion to stabilize extended foldamer b-strand mime-
tics,[15d,e] herein we report the rational design of a range of
monomers with different innate folding preferences, analo-
gous to amino acid SSPs.[20] These allow the selective
formation of helical or extended domains within a single
foldamer, formed by an iterative cross-coupling strategy. We
theorized that use of three isomeric aromatic linkers (pyra-
zine, pyridazine, and pyrimidine) would lead to different
conformational preferences in aryl-linked imidazolidine-2-
one oligomers, as determined by dipolar repulsion between
the urea carbonyl groups and adjacent arene nitrogen lone
pairs (Figure 1B). The effect would be that the pyrazine and
pyridazine linkers would stabilize extended conformations,
while the pyrimidine linker would form curved or helical
structures.[11, 12]
Our iterative approach to the foldamers required the
synthesis of pyrimidine (3), pyridazine (4), and pyrazine (5)
monomers, which was achieved from common intermediates
1 and 2 (Scheme 1).[21] Buchwald–Hartwig coupling of 2 with
4,6-dichloropyrimidine, and of 1 with 3,6-dibromopyridazine
and 2,5-dibromopyrazine, afforded monomers 3, 4, and 5 in
73%, 63%, and 53% yields, respectively. The conformations
of monomers 3–5 were examined by single-crystal X-ray
diffraction.[22] In all cases the urea carbonyl is oriented anti to
the ortho-nitrogen atom on the adjacent heterocycle, in line
with the dipole repulsion hypothesis.
The conformational preferences of the corresponding
oligomers were then investigated. Ureas 6 and 8 were formed
according to literature methods,[21] and used as the starting
point for the iterative synthesis of oligomers (Scheme 2), with
the N@Ph acting as a terminal inert capping group and
internal standard for subsequent nOe analyses (see below).
Deprotection with thiophenol and K2CO3 liberated ureas 7
and 9, and cross-coupling of the former with 3, and the latter
with 4 and 5, afforded dimeric compounds 10, 11, and 12 in
72%, 99%, and 91% yields, respectively. The conformations
of all dimers[23] were examined by single-crystal X-ray
diffraction (Figure 2).[22] In all cases the urea C=O bonds
are oriented anti to the ortho-nitrogen lone pair of the
adjacent heteroaromatic ring. For pyrimidine 10 this has the
effect that the molecule is highly curved; the monomer
induces an 868 turn in the backbone, such that a helix
composed of this motif would contain about four residues per
turn. For 11 and 12, the presence of para-substituted
pyridazine and pyrazine linkers led to greater linearity, with
monomer-induced curvatures of 1548 and 1398 respectively. It
is likely that longer pyrazine-containing foldamers would
form overall linear conformers due to the alternating
disposition of the ureas (Figure 2, cartoon). The control
exacted by dipole repulsion also leads to predictable position-
ing of the side-chains (Figure 2, right). While the distances
Scheme 2. Synthesis of dimers 10 (top), 11 (middle), and 12 (bottom)
from terminal monomers 7 and 9. Imidazolidin-2-one side-chains are
highlighted in circles. *After 22 h an additional charge of Pd2dba3
(5 mol%) and Xantphos (15 mol%) was added. The reaction pro-
ceeded to completion after a further 3 h.
Figure 2. X-ray crystal structures of dimeric foldamers 10 (top), 11
(middle) and 12 (bottom).[22] Left: the top elevation gives the deviation
(in degrees) each monomer induces in the foldamer, where an angle
of 1808 would represent perfect linearity. Side-chains are highlighted in
green and red. Cartoon representations of the extrapolated conforma-
tion of larger homo-oligomers are given below each structure. Right:
the edge elevation shows the disposition of side-chain residues relative
to the plane of the foldamer, and the distances between the Ca
positions (in b).
Scheme 1. Synthesis of monomers 3–5 via Buchwald–Hartwig cross-
coupling. Single-crystal X-ray structures[22] show that all compounds
adopt the conformation in which dipoles are opposed. Coupling
conditions: aryl dihalide (5 equiv), Pd2dba3 (5 mol%), Xantphos
(15 mol%), Cs2CO3, PhMe, reflux, 30 min @4 h. Bn=benzyl, dba=di-
benzylideneacetone, Ns=2-nitrobenzenesulfonyl, Xantphos=4,5-bis-
(diphenylphosphino)-9,9-dimethylxanthene.
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between the Ca positions are largely unchanged across the
three homo-dimers (8.1–8.7c), the facial projection of
substituents from the plane of the foldamer is dependent on
the heterocyclic linker. Thus, for the pyrimidine and pyrid-
azine foldamers, side-chains are projected from the same face
of the molecule, while the pyrazine linker leads to adjacent
side-chains occupying opposite faces.
The solution-phase conformational behaviour of the
dimers was examined through nuclear Overhauser effect
(nOe) correlations. For pyrimidine 10 these indicate a strong
preference towards the dipole-opposed, curved conformation
(Figure 3).
The rotating frame nuclear Overhauser effect (ROESY)
cross-peaks of both H7 and H15 with both H11 and H12 were of
similar intensity, in agreement with the distances observed in
the crystal structure. Similarly, the observed H8$H11 nOe
indicates that the solid- and solution-phase conformations are
in agreement, since these hydrogen atoms would be too
distant for an observable nOe in the alternative, dipoles-syn
conformation. In line with previous analyses,[15e,21] the N@Ph
group was used as an internal standard to assess conforma-
tion; it is assumed that a freely rotating N@C13 bond would
lead to an observed nOe intensity ratio between H12$H15 and
H3$H6 of 1:2. The observed ratio was 1:25 in CDCl3,[24]
indicating a strong biasing effect in solution. In 100%
[D6]DMSO at 298 K the H
12$H15 :H3$H6 nOe ratio was
1:41, and an additional H3$H12 signal was observed, suggest-
ing the molecule retains its strong preference for the dipole-
opposed conformation in highly polar solvents. When warmed
to 355 k the H12$H15 :H3$H6 nOe ratio in [D6]DMSO fell to
1:11, suggesting a reduction in (but not loss of) conforma-
tional rigidity at elevated temperature. Analogous results
(excluding [D6]DMSO and variable-temperature experi-
ments) were obtained for pyridazine and pyrazine dimers 11
and 12 (see the Supporting Information).
Homo-trimers 13, 14, and 15, and tetramer 16 (Figure 4)
were formed by the same iterative deprotection–coupling
sequence outlined in Scheme 2. Their ROESY spectra were
consistent with these foldamers adopting the conformations
predicted by the dipole repulsion hypothesis, with indicative
couplings analogous to those in Figure 3 (see also the
Supporting Information).
Tetramer 16 gave several long-range nOe correlations
(Figure 4), indicating that its ends sit in close proximity, as
expected on the basis of the 868 turn per monomer outlined in
Figure 2. When compared with the computed low-energy
structure,[25] these nOes correspond to close contacts in the
global minimum, suggesting the (P)-helical conformation is
significantly populated in solution. The circular dichroism
spectrum of 16 displayed positive and negative Cotton effects
at 300 nm and 285 nm respectively that were absent from the
spectra of homologous pyrimidine dimer 10 and trimer 13,
and may be diagnostic of (P)-helix formation.[26]
Lastly we examined whether the conformational prefer-
ences established above were borne out in hetero-oligomers.
These are expected to form structures containing distinct
conformational domains, as determined by the constituent
monomers. Trimers 21 and 22 were synthesized by the
iterative route detailed in Scheme 2, while pentamer 20 was
formed in 50% yield via a convergent strand-coupling
approach from trimeric fragment 17 and dimeric 19
(Figure 5; for complete synthetic details refer to the Support-
ing Information).
The solution-phase conformations of these foldamers
were probed by examining their ROESY spectra.
On the basis of the results obtained for the homo-
oligomers, hetero-trimer 22 (Figure 5, right) was expected to
favour a conformation curved at the pyrimidine and linear at
the pyridazine linkers along its backbone. This was found to
be the case, with the observation of several key nOe
correlations, namely H3$H11, H7$H13, H8$H13, and
H13$H15, indicating a strong preference for the predicted
conformations about both N@Cpyrimidine bonds (as shown).
Similarly, the absence of H16$H20 and H21$H24 correlations
is consistent with the illustrated conformation around both
N@Cpyridazine bonds. Foldamers 20 and 21 displayed analogous
spectral features, indicating that they adopt the dipole-
opposed conformations depicted in Figure 5 (see also the
Supporting Information). This confirms that the design
Figure 3. nOe correlations from the ROESY spectrum of 10 (CDCl3,
600 MHz, tmix 200 ms). Solid black arrows are strong cross-peaks;
dashed red arrows are weak cross-peaks. Selected atomic numbering
given in blue. Numbers (in boxes) given to 1 d.p. indicate measured
inter-proton distances from the X-ray crystal structure (in b). *H15
and H15’ are isochronous in the 1H spectrum so distances for both
diastereotopic hydrogens are given.
Figure 4. Top: library of homo-oligomers 13–16 synthesized through
iterative cross-coupling. Bottom: arrows indicate observed long-range
nOes of pyrimidine tetramer 16 (left) and its unconstrained lowest
energy conformation (middle).[25] Atom numbers are indicated in blue.
The distances given (right) are from the energy-minimized structure.
Where distances are measured to H9’, the values given are an average
across the three hydrogen atom positions.
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strategy described herein allows the construction of bespoke
oligomers with predictable, non-repetitive conformations.
In conclusion, we have developed a chiral amino alcohol-
derived foldamer backbone incorporating pyrimidine, pyrid-
azine, and pyrazine linkers, synthesized primarily through an
iterative deprotection-coupling sequence. These foldamers
reliably adopt conformations which can be predicted using
a simple dipolar repulsion argument, even in highly polar
solvents. As well as giving control of the overall backbone
shape, this permits the projection of side-chains frommultiple
faces of the foldamer by choice of linker, enabling rapid and
programmable exploration of macromolecular conforma-
tional space.
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